Factors Associated with Completion of Treatment Course with Lutetium-177 Vipivotide Tetraxetan in Men with Metastatic Castration-Resistant Prostate Cancer at a Single Institution

Autor: Kieft, A.L., Whatts, P., Miller II, S.R.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:e596-e596
Databáze: ScienceDirect